Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - Marinomed, Pierer Mobility (14/06/2024)

16.06.2024

Marinomed: Marinomed Biotech AG expands its license regarding the distribution of Marinomed’s Carragelose products with an existing partner and leading Consumer Health Care market player. The agreement provides for the marketing and distribution of Carragelose products in several EU-countries and some non-EU countries pending any required regulatory approvals. Under the terms of the agreement and depending on the achievement of specified regulatory and commercial targets, Marinomed is eligible to receive milestone payments. “Broadening our license with a leading Consumer Health Company is a huge success and validation of our Carragelose product line”, Andreas Grassauer, CEO of Marinomed, comments. “Expanding to additional countries is another significant step for our business, and we are looking forward to realizing the full potential of our products.”
Marinomed Biotech: weekly performance: 0.38%

Pierer Mobility: In the current financial year, momentum in PIERER Mobility's core motorbike markets in the USA and Europe has slowed significantly. For the 2024 financial year, the Executive Board expects a decline in sales of 10% to 15% for both the motorcycles and bicycle divisions due to the current market developments. In the Motorcycles segment, the Executive Board assumes that the cost savings introduced in the current financial year will be able to compensate for the negative effects of declining sales to such an extent that a balanced to slightly positive EBIT can be generated. The development of existing dealers and the further expansion of the dealer network to support the brand strategy will be key issues in 2024. In the Bicycle division, however, the Executive Board anticipates a significantly negative EBIT of €-110 to €-130 million for the 2024 financial year, which is essentially due to extraordinary impairment and restructuring requirements. The restructuring of the Bicycle division is therefore complete. 
Pierer Mobility: weekly performance: -2.21%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (14/06/2024)


Partners









latest 21st Austria

21st Austria weekly - Marinomed, Pierer Mobility (14/06/2024)


16.06.2024, 2077 Zeichen



Marinomed: Marinomed Biotech AG expands its license regarding the distribution of Marinomed’s Carragelose products with an existing partner and leading Consumer Health Care market player. The agreement provides for the marketing and distribution of Carragelose products in several EU-countries and some non-EU countries pending any required regulatory approvals. Under the terms of the agreement and depending on the achievement of specified regulatory and commercial targets, Marinomed is eligible to receive milestone payments. “Broadening our license with a leading Consumer Health Company is a huge success and validation of our Carragelose product line”, Andreas Grassauer, CEO of Marinomed, comments. “Expanding to additional countries is another significant step for our business, and we are looking forward to realizing the full potential of our products.”
Marinomed Biotech: weekly performance: 0.38%

Pierer Mobility: In the current financial year, momentum in PIERER Mobility's core motorbike markets in the USA and Europe has slowed significantly. For the 2024 financial year, the Executive Board expects a decline in sales of 10% to 15% for both the motorcycles and bicycle divisions due to the current market developments. In the Motorcycles segment, the Executive Board assumes that the cost savings introduced in the current financial year will be able to compensate for the negative effects of declining sales to such an extent that a balanced to slightly positive EBIT can be generated. The development of existing dealers and the further expansion of the dealer network to support the brand strategy will be key issues in 2024. In the Bicycle division, however, the Executive Board anticipates a significantly negative EBIT of €-110 to €-130 million for the 2024 financial year, which is essentially due to extraordinary impairment and restructuring requirements. The restructuring of the Bicycle division is therefore complete. 
Pierer Mobility: weekly performance: -2.21%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (14/06/2024)



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #679: Heute gleich 7 Austro-IPO-Geburtstage, wieviele wisst Ihr? Verbund nice, it´s fun to stay at the FACC




 

Bildnachweis

Aktien auf dem Radar:Immofinanz, Warimpex, Addiko Bank, Austriacard Holdings AG, Semperit, Lenzing, Frequentis, Pierer Mobility, FACC, Wienerberger, Palfinger, Cleen Energy, SW Umwelttechnik, Oberbank AG Stamm, Amag, Agrana, CA Immo, Erste Group, EVN, Flughafen Wien, Österreichische Post, Polytec Group, Telekom Austria, Uniqa, VIG.


Random Partner

EuroTeleSites AG
EuroTeleSites bietet mit seiner langjähriger Erfahrung im Bereich der Telekommunikation, Lösungen und Dienstleistungen zum Bau und der Servicierung von drahtlosen Telekommunikationsnetzwerken in sechs Ländern in der CEE-Region an: Österreich, Bulgarien, Kroatien, Slowenien, der Republik Nordmazedonien und der Republik Serbien. Das Portfolio des Unternehmens umfasst über 13.000 Standorte, die hochwertige Wholesale Services für eine breite Palette von Kunden bieten.

>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten